Melphalan Hydrochloride vs Rituximab
Melphalan Hydrochloride vs Rituximab: Overview
This comparison examines the pharmacological differences between Melphalan Hydrochloride and Rituximab.
Mechanism of Action
Rituximab: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.
Pharmacokinetics
Half-life: Rituximab β 22 days.
Chemical Properties
Type: Melphalan Hydrochloride β Small molecule; Rituximab β Antibody.